 | | | | Eli Lilly will gain exclusive worldwide license to Rigel Pharmaceuticals Inc's autoimmune and inflammatory diseases treatment, including its lead candidate, R552, for potentially up to $960 million, the companies said on Thursday. | | | | | | Guinea expects to receive more than 11,000 Ebola vaccines this weekend, with more to follow, and inoculations could start as soon as Monday, a health ministry official and the World Health Organization said on Thursday. | | | | | | A study of residents in the ski resort of Ischgl, the site of Austria's worst coronavirus outbreak, found that at least eight months after contracting the virus the vast majority of people remained immune, scientists who conducted it said on Thursday. | | | | | | Zimbabwe kicked-off its COVID-19 vaccination programme on Thursday after receiving a donation of 200,000 doses of the Sinopharm vaccine from China earlier in the week. | | | | | | Only 55% of Black people in England aged between 70 to 79 had been vaccinated against COVID-19 by Feb. 11, compared to 86% of white people in this age group, according to early research on England's coronavirus vaccination programme. | | | | | | Here's what you need to know about the coronavirus right now: | | | | | | The second dose of Pfizer Inc's COVID-19 vaccine could be delayed in order to cover all priority groups as the first one is highly protective, two Canada-based researchers said in a letter published in the New England Journal of Medicine. | | | | | | In Mexico City, one of the world's biggest cities, a product that many women relied on as a monthly necessity is gradually disappearing from the shelves: tampons with plastic applicators. | | | | | | Denmark's Supreme Court on Thursday sentenced a man to four months' imprisonment for coughing at two police officers while shouting "corona" during a routine traffic stop in March last year. | | | | | | The Vatican has told employees that they may risk losing their jobs if they refuse to get a COVID-19 vaccination without legitimate health reasons. | | | | | | South African scientists will hold discussions on Thursday on a laboratory study that suggests the dominant local variant of the coronavirus may reduce antibody protection from Pfizer's COVID-19 vaccine by two-thirds. | | | | | |
